Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genes from the 18th century help patients of today

07.01.2011
Mainz University Paleogenetics Group participates in study of acromegaly attributable to genetic mutation / Publication in renowned New England Journal of Medicine

An international research team, spearheaded by scientists from the London School of Medicine and Dentistry, has identified the genetic mutation responsible for a disease known as "gigantism" or acromegaly. The results of the study – conducted, among others, by the Paleogenetics Group of the Institute of Anthropology at Johannes Gutenberg University Mainz (JGU), Germany – were recently published in the renowned New England Journal of Medicine. It is hoped that these will help in the treatment of patients suffering from acromegaly.

Gigantism is known to be caused by a tumor of the pituitary gland, a gland located at the base of the brain from where it releases hormones that regulate several functions of the body – one being growth. Pituitary tumors can cause tissues to grow abnormally resulting in certain changes in facial appearance, enlarged hands and feet, headache and sweating – eyesight too can be affected; this condition is called acromegaly.

Márta Korbonits, Professor of Endocrinology and Metabolism at Barts and the London School of Medicine and Dentistry, initially looked at the aryl hydrocarbon receptor interacting protein (AIP) gene. It has been known since 2006 that defects to this gene are associated with a predisposition to development of pituitary tumors, and Professor Korbonits was able to identify a specific genetic mutation in Irish patients with a family history of acromegaly. Leading international paleogenetics experts Professor Dr Joachim Burger and Martina Unterländer of the Institute of Anthropology at Johannes Gutenberg University Mainz, Germany subsequently extracted and analyzed the DNA from the skeleton of an 18th-century acromegaly patient preserved in the Hunterian Museum in London. The research team discovered exactly the same mutation as the one found in living patients. Further analyses of other DNA segments located in the vicinity of this gene led to the conclusion that the Hunterian Museum's so-called "Irish Giant" had inherited the mutation from a common ancestor that he shared with a number of living Irish families who are suffering from this hereditary disorder today. The subsequent complex biostatistical calculations showed that the original mutation developed around 1,500 years ago and has been passed on from generation to generation ever since. It is estimated that around 200 to 300 people still carry the mutation today.

"The ancient DNA from the skeleton has enabled us to confirm the hypothesis that there is indeed a link between the mutation and this disease, a disorder which in the past so often resulted in tragedy," explains Professor Joachim Burger from Mainz University. He continues: "The biomathematical calculations have even provided us with a highly accurate insight into the history of this illness." Márta Korbonits, head of the study, adds: " The most important clinical aspect of our study is that it is now possible to trace down carriers of this gene in time and treat patients before they grow to be a giant." Professor Patrick Morrison, co-author of the study, concludes: "The benefits to patients locally are that we now have a genetic blood test that families at risk of this condition can choose to have, which allows early detection and prevention of excessive growth."

Petra Giegerich | idw
Further information:
http://www.uni-mainz.de/eng/13999.php
http://www.nejm.org/doi/pdf/10.1056/NEJMoa1008020

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>